Journal article
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort
Abstract
BACKGROUND: Severe haemophilia A has high morbidity, and treatment, while effective, is very expensive. We report the 16-year follow-up of the Canadian Hemophilia Prophylaxis Study, which examined the effectiveness of tailored frequency-escalated primary prophylaxis with a focus on health outcomes within the domains of body structures and functions, and activities and participation (according to the WHO International Classification of …
Authors
Feldman BM; Rivard GE; Babyn P; Wu JKM; Steele M; Poon M-C; Card RT; Israels SJ; Laferriere N; Gill K
Journal
The Lancet Haematology, Vol. 5, No. 6, pp. e252–e260
Publisher
Elsevier
Publication Date
6 2018
DOI
10.1016/s2352-3026(18)30048-6
ISSN
2352-3026